Sotera Health (NYSE: SHC) is one of 27 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare Sotera Health to related businesses based on the strength of its risk, dividends, earnings, profitability, institutional ownership, valuation and analyst recommendations.
This table compares Sotera Health and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Sotera Health Competitors||-39.15%||16.05%||-9.95%|
This is a breakdown of current recommendations and price targets for Sotera Health and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Sotera Health Competitors||92||389||536||15||2.46|
Sotera Health presently has a consensus price target of $32.15, suggesting a potential upside of 31.44%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 8.00%. Given Sotera Health’s stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than its competitors.
Institutional and Insider Ownership
87.6% of Sotera Health shares are owned by institutional investors. Comparatively, 43.2% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by institutional investors. 65.0% of Sotera Health shares are owned by insiders. Comparatively, 26.4% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Sotera Health and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Sotera Health||$818.16 million||-$38.62 million||64.37|
|Sotera Health Competitors||$1.94 billion||$96.17 million||42.17|
Sotera Health’s competitors have higher revenue and earnings than Sotera Health. Sotera Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Sotera Health beats its competitors on 8 of the 12 factors compared.
Sotera Health Company Profile
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.